Robin Reschke, physician scientist at the University Hospital Heidelberg, shared a post on LinkedIn:
“HARPOON (DKFZ/NCT/DKTK) Conference 2025 — PREDICT Study Insights
I am genuinely happy to play a small part in such a high-quality scientific meeting and grateful for the opportunity to share our latest results from the PREDICT study, which I am proud to co-lead together with Prof. Jessica Hassel.
HARPOON is bringing together top experts in precision-oncology.
With a large, deeply profiled cohort, PREDICT is a step towards personalized immunotherapy risk stratification and improved patient safety.”
More posts featuring Robin Reschke on OncoDaily.